These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 38406573)

  • 21. Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation.
    Hyeon S; Lee H; Yang Y; Jeong W
    Free Radic Biol Med; 2013 Dec; 65():789-799. PubMed ID: 23954472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells.
    Kondo H; Guo J; Bringhurst FR
    J Bone Miner Res; 2002 Sep; 17(9):1667-79. PubMed ID: 12211438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic Activation of Activin A Signaling Causes Chronic Kidney Disease-Mineral Bone Disorder.
    Sugatani T
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Translational Medicine in Pulmonary-Renal Crosstalk: Therapeutic Targeting of p-Cresyl Sulfate Triggered Nonspecific ROS and Chemoattractants in Dyspneic Patients with Uremic Lung Injury.
    Chang JF; Liang SS; Thanasekaran P; Chang HW; Wen LL; Chen CH; Liou JC; Yeh JC; Liu SH; Dai HM; Lin WN
    J Clin Med; 2018 Sep; 7(9):. PubMed ID: 30205620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uremic toxins of organic anions up-regulate PAI-1 expression by induction of NF-kappaB and free radical in proximal tubular cells.
    Motojima M; Hosokawa A; Yamato H; Muraki T; Yoshioka T
    Kidney Int; 2003 May; 63(5):1671-80. PubMed ID: 12675842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can Resveratrol Supplementation Reduce Uremic Toxin Plasma Levels From the Gut Microbiota in Nondialyzed Patients With Chronic Kidney Disease?
    Alvarenga L; Cardozo LFMF; Leal VO; Kemp JA; Saldanha JF; Ribeiro-Alves M; Meireles T; Nakao LS; Mafra D
    J Ren Nutr; 2022 Nov; 32(6):685-691. PubMed ID: 35122992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The uraemic toxin phenylacetic acid inhibits osteoblastic proliferation and differentiation: an implication for the pathogenesis of low turnover bone in chronic renal failure.
    Yano S; Yamaguchi T; Kanazawa I; Ogawa N; Hayashi K; Yamauchi M; Sugimoto T
    Nephrol Dial Transplant; 2007 Nov; 22(11):3160-5. PubMed ID: 17640942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxico-pharmacological perspective of the Nrf2-Keap1 defense system against oxidative stress in kidney diseases.
    Saito H
    Biochem Pharmacol; 2013 Apr; 85(7):865-72. PubMed ID: 23333765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indoxyl sulfate exacerbates low bone turnover induced by parathyroidectomy in young adult rats.
    Hirata J; Hirai K; Asai H; Matsumoto C; Inada M; Miyaura C; Yamato H; Watanabe-Akanuma M
    Bone; 2015 Oct; 79():252-8. PubMed ID: 26112820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets.
    Lim YJ; Sidor NA; Tonial NC; Che A; Urquhart BL
    Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33668632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PTH differentially regulates expression of RANKL and OPG.
    Huang JC; Sakata T; Pfleger LL; Bencsik M; Halloran BP; Bikle DD; Nissenson RA
    J Bone Miner Res; 2004 Feb; 19(2):235-44. PubMed ID: 14969393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.
    Kamiński TW; Pawlak K; Karbowska M; Myśliwiec M; Pawlak D
    BMC Nephrol; 2017 Jan; 18(1):35. PubMed ID: 28122514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indoxyl sulfate and p-cresyl sulfate in chronic kidney disease. Could these toxins modulate the antioxidant Nrf2-Keap1 pathway?
    Stockler-Pinto MB; Fouque D; Soulage CO; Croze M; Mafra D
    J Ren Nutr; 2014 Sep; 24(5):286-91. PubMed ID: 24480117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment with pravastatin attenuates oxidative stress and protects osteoblast cell viability from indoxyl sulfate.
    Iwasaki Y; Yamato H; Fukagawa M
    Ther Apher Dial; 2011 Apr; 15(2):151-5. PubMed ID: 21426507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3-4 chronic kidney disease.
    Rossi M; Campbell KL; Johnson DW; Stanton T; Vesey DA; Coombes JS; Weston KS; Hawley CM; McWhinney BC; Ungerer JP; Isbel N
    Arch Med Res; 2014 May; 45(4):309-17. PubMed ID: 24751327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting protein-bound uremic toxins in chronic kidney disease.
    Niwa T
    Expert Opin Ther Targets; 2013 Nov; 17(11):1287-301. PubMed ID: 23941498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins.
    Lau WL; Savoj J; Nakata MB; Vaziri ND
    Clin Sci (Lond); 2018 Mar; 132(5):509-522. PubMed ID: 29523750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography/tandem mass spectrometry and their effects on endothelial ROS production.
    Itoh Y; Ezawa A; Kikuchi K; Tsuruta Y; Niwa T
    Anal Bioanal Chem; 2012 Jun; 403(7):1841-50. PubMed ID: 22447217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxidized low density lipoprotein enhanced RANKL expression in human osteoblast-like cells. Involvement of ERK, NFkappaB and NFAT.
    Mazière C; Salle V; Gomila C; Mazière JC
    Biochim Biophys Acta; 2013 Oct; 1832(10):1756-64. PubMed ID: 23756197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Impact of CKD on Uremic Toxins and Gut Microbiota.
    Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
    Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.